MATTHEW W FOEHR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATTHEW W FOEHR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW W FOEHR. MATTHEW W FOEHR is President and COO in LIGAND PHARMACEUTICALS INC ($LGND) and Sr. VP Technical Operations in CONNETICS CORP ($CNCT) and Director in RITTER PHARMACEUTICALS INC ($RTTR) and Director in Viking Therapeutics, Inc. ($VKTX).
Latest Insider Trading Transactions of MATTHEW W FOEHR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CNCT, LGND, RTTR, VKTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | X | 1.50 | 20,000 | 30,000 | 0 | |
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | X | 1.50 | 20,000 | 30,000 | 46,250 | 26.3 K to 46.3 K (+76.19 %) |
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | X | 1.50 | 20,000 | 30,000 | 0 | |
Mar 25 2021 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | X | 1.50 | 20,000 | 30,000 | 46,250 | 26.3 K to 46.3 K (+76.19 %) |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | A | 177.50 | 13,136 | 2,331,640 | 13,136 | |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 74.42 | 1,000 | 74,420 | 63,210 | |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 44,547 | 976,470 | 20,000 | |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 176.86 | 44,547 | 7,878,582 | 168,198 | 212.7 K to 168.2 K (-20.94 %) |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 44,547 | 976,470 | 212,745 | 168.2 K to 212.7 K (+26.48 %) |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 74.42 | 1,000 | 74,420 | 168,198 | 167.2 K to 168.2 K (+0.60 %) |
Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 6,595 | 0 | 167,198 | 160.6 K to 167.2 K (+4.11 %) |
Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 156.01 | 2,272 | 354,455 | 160,603 | 162.9 K to 160.6 K (-1.39 %) |
Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 5,604 | 0 | 162,875 | 157.3 K to 162.9 K (+3.56 %) |
Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 156.01 | 1,053 | 164,279 | 157,271 | 158.3 K to 157.3 K (-0.67 %) |
Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 2,911 | 0 | 158,324 | 155.4 K to 158.3 K (+1.87 %) |
Aug 25 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 74.42 | 790 | 58,792 | 64,210 | |
Aug 25 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 78 | 1,710 | 64,547 | |
Aug 25 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 7,225 | 104,546 | 0 | |
Aug 25 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 110.89 | 78 | 8,649 | 155,413 | 155.5 K to 155.4 K (-0.05 %) |
Aug 25 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 78 | 1,710 | 155,491 | 155.4 K to 155.5 K (+0.05 %) |
Aug 25 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 112.88 | 7,225 | 815,541 | 155,413 | 162.6 K to 155.4 K (-4.44 %) |
Aug 25 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 7,225 | 104,546 | 162,638 | 155.4 K to 162.6 K (+4.65 %) |
Aug 25 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 74.42 | 790 | 58,792 | 155,413 | 154.6 K to 155.4 K (+0.51 %) |
Jun 30 2020 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Sell | S | 7.35 | 13,000 | 95,550 | 26,250 | 39.3 K to 26.3 K (-33.12 %) |
Apr 24 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 120.86 | 642 | 77,592 | 122,727 | 123.4 K to 122.7 K (-0.52 %) |
Apr 24 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 120.86 | 1,246 | 150,592 | 123,369 | 124.6 K to 123.4 K (-1.00 %) |
Apr 24 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 120.86 | 938 | 113,367 | 124,615 | 125.6 K to 124.6 K (-0.75 %) |
Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | D | 1.30 | 38,461 | 49,999 | 0 | |
Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | C | 1.30 | 100 | 130 | 0 | |
Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Grant | A | 0.00 | 38,461 | 0 | 138,635 | 100.2 K to 138.6 K (+38.39 %) |
Apr 23 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | C | 0.00 | 76,923 | 0 | 100,174 | 23.3 K to 100.2 K (+330.84 %) |
Mar 13 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 2,000 | 43,840 | 64,625 | |
Mar 13 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 2,000 | 43,840 | 157,449 | 155.4 K to 157.4 K (+1.29 %) |
Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 1,706 | 37,396 | 66,625 | |
Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 7,225 | 104,546 | 7,225 | |
Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 1,706 | 37,396 | 155,449 | 153.7 K to 155.4 K (+1.11 %) |
Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 110.00 | 7,225 | 794,750 | 153,743 | 161 K to 153.7 K (-4.49 %) |
Feb 27 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 7,225 | 104,546 | 160,968 | 153.7 K to 161 K (+4.70 %) |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | A | 95.68 | 33,210 | 3,177,533 | 33,210 | |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 496 | 10,872 | 68,331 | |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 7,225 | 104,546 | 14,450 | |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 97.23 | 1,170 | 113,759 | 153,743 | 154.9 K to 153.7 K (-0.76 %) |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 97.23 | 447 | 43,462 | 154,913 | 155.4 K to 154.9 K (-0.29 %) |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 97.23 | 869 | 84,493 | 155,360 | 156.2 K to 155.4 K (-0.56 %) |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 95.84 | 7,225 | 692,467 | 156,229 | 163.5 K to 156.2 K (-4.42 %) |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 7,225 | 104,546 | 163,454 | 156.2 K to 163.5 K (+4.62 %) |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 7,396 | 0 | 156,229 | 148.8 K to 156.2 K (+4.97 %) |
Feb 18 2020 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 496 | 10,872 | 148,833 | 148.3 K to 148.8 K (+0.33 %) |
Jan 17 2020 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.23 | 12,000 | 2,760 | 12,000 | |
Jan 03 2020 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 7.95 | 22,000 | 174,900 | 22,000 | |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 105.87 | 1,444 | 152,876 | 148,337 | 149.8 K to 148.3 K (-0.96 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 2,913 | 0 | 149,781 | 146.9 K to 149.8 K (+1.98 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 105.87 | 2,210 | 233,973 | 146,868 | 149.1 K to 146.9 K (-1.48 %) |
Dec 26 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 4,458 | 0 | 149,078 | 144.6 K to 149.1 K (+3.08 %) |
Nov 13 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 1,001 | 21,942 | 68,827 | |
Nov 13 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 1,001 | 21,942 | 144,620 | 143.6 K to 144.6 K (+0.70 %) |
Sep 05 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 1,005 | 22,030 | 69,828 | |
Sep 05 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 1,005 | 22,030 | 143,619 | 142.6 K to 143.6 K (+0.70 %) |
Aug 13 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 1,163 | 25,493 | 70,833 | |
Aug 13 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 1,163 | 25,493 | 142,614 | 141.5 K to 142.6 K (+0.82 %) |
Jun 12 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 21.92 | 1,004 | 22,008 | 71,996 | |
Jun 12 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 21.92 | 1,004 | 22,008 | 141,451 | 140.4 K to 141.5 K (+0.71 %) |
Mar 15 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 14,894 | 148,493 | 15,001 | |
Mar 15 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 14,894 | 148,493 | 140,447 | 125.6 K to 140.4 K (+11.86 %) |
Feb 13 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | A | 117.97 | 34,181 | 4,032,333 | 34,181 | |
Feb 13 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 7,472 | 0 | 125,553 | 118.1 K to 125.6 K (+6.33 %) |
Feb 08 2019 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.60 | 15,000 | 9,000 | 15,000 | |
Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 111.78 | 1,284 | 143,526 | 118,081 | 119.4 K to 118.1 K (-1.08 %) |
Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 3,715 | 0 | 119,365 | 115.7 K to 119.4 K (+3.21 %) |
Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 111.78 | 1,284 | 143,526 | 115,650 | 116.9 K to 115.7 K (-1.10 %) |
Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 3,547 | 0 | 116,934 | 113.4 K to 116.9 K (+3.13 %) |
Jan 03 2019 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 8.32 | 22,000 | 183,040 | 22,000 | |
Dec 12 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 7,999 | 79,750 | 29,895 | |
Dec 12 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 7,999 | 79,750 | 113,387 | 105.4 K to 113.4 K (+7.59 %) |
Nov 07 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | P | 1.30 | 38,461 | 49,999 | 38,461 | |
Nov 07 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | P | 1.30 | 100 | 130 | 100 | |
Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 12,000 | 173,640 | 21,675 | |
Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 2,088 | 20,817 | 37,894 | |
Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 273.88 | 12,000 | 3,286,560 | 105,388 | 117.4 K to 105.4 K (-10.22 %) |
Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 12,000 | 173,640 | 117,388 | 105.4 K to 117.4 K (+11.39 %) |
Oct 02 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 2,088 | 20,817 | 105,388 | 103.3 K to 105.4 K (+2.02 %) |
Sep 05 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 12,000 | 173,640 | 33,675 | |
Sep 05 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 1,044 | 10,409 | 39,982 | |
Sep 05 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 255.01 | 12,000 | 3,060,082 | 103,300 | 115.3 K to 103.3 K (-10.41 %) |
Sep 05 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 12,000 | 173,640 | 115,300 | 103.3 K to 115.3 K (+11.62 %) |
Sep 05 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 1,044 | 10,409 | 103,300 | 102.3 K to 103.3 K (+1.02 %) |
Aug 20 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 2.04 | 19,751 | 40,292 | 54,751 | 35 K to 54.8 K (+56.43 %) |
May 11 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 8,881 | 128,508 | 45,675 | |
May 11 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 1,055 | 10,518 | 41,026 | |
May 11 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 1,055 | 10,518 | 102,256 | 101.2 K to 102.3 K (+1.04 %) |
May 11 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 167.63 | 8,881 | 1,488,687 | 101,201 | 110.1 K to 101.2 K (-8.07 %) |
May 11 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 8,881 | 128,508 | 110,082 | 101.2 K to 110.1 K (+8.78 %) |
Mar 06 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | A | 159.01 | 20,274 | 3,223,769 | 20,274 | |
Mar 06 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 165.87 | 1,457 | 241,673 | 101,201 | 102.7 K to 101.2 K (-1.42 %) |
Mar 06 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 2,940 | 0 | 102,658 | 99.7 K to 102.7 K (+2.95 %) |
Mar 06 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 3,883 | 0 | 99,718 | 95.8 K to 99.7 K (+4.05 %) |
Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 14.47 | 5,444 | 78,775 | 54,556 | |
Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 1,004 | 10,010 | 42,081 | |
Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 152.98 | 5,444 | 832,824 | 95,835 | 101.3 K to 95.8 K (-5.38 %) |
Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 14.47 | 5,444 | 78,775 | 101,279 | 95.8 K to 101.3 K (+5.68 %) |
Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 1,004 | 10,010 | 95,835 | 94.8 K to 95.8 K (+1.06 %) |
Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 157.18 | 1,246 | 195,846 | 94,831 | 96.1 K to 94.8 K (-1.30 %) |
Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 157.18 | 906 | 142,405 | 96,077 | 97 K to 96.1 K (-0.93 %) |
Feb 16 2018 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 157.18 | 1,511 | 237,499 | 96,983 | 98.5 K to 97 K (-1.53 %) |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 25 2018 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 0.34 | 30,000 | 10,200 | 30,000 | |
Jan 03 2018 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 4.48 | 16,000 | 71,680 | 16,000 | |
Dec 29 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 138.66 | 2,971 | 411,959 | 98,494 | 101.5 K to 98.5 K (-2.93 %) |
Dec 29 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 5,695 | 0 | 101,465 | 95.8 K to 101.5 K (+5.95 %) |
Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 850 | 8,475 | 43,085 | |
Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 6,100 | 60,817 | 43,935 | |
Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 850 | 8,475 | 95,770 | 94.9 K to 95.8 K (+0.90 %) |
Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 127.51 | 6,100 | 777,824 | 94,920 | 101 K to 94.9 K (-6.04 %) |
Aug 10 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 6,100 | 60,817 | 101,020 | 94.9 K to 101 K (+6.43 %) |
May 18 2017 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 0.62 | 18,000 | 11,155 | 35,000 | 17 K to 35 K (+105.88 %) |
May 15 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 2,200 | 21,934 | 50,035 | |
May 15 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 5,621 | 56,041 | 52,235 | |
May 15 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 2,200 | 21,934 | 94,920 | 92.7 K to 94.9 K (+2.37 %) |
May 15 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 112.20 | 5,621 | 630,650 | 92,720 | 98.3 K to 92.7 K (-5.72 %) |
May 15 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 5,621 | 56,041 | 98,341 | 92.7 K to 98.3 K (+6.06 %) |
Mar 03 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 2,000 | 19,940 | 57,856 | |
Mar 03 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 6,879 | 68,584 | 59,856 | |
Mar 03 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 2,000 | 19,940 | 92,720 | 90.7 K to 92.7 K (+2.20 %) |
Mar 03 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 103.39 | 6,879 | 711,214 | 90,720 | 97.6 K to 90.7 K (-7.05 %) |
Mar 03 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 6,879 | 68,584 | 97,599 | 90.7 K to 97.6 K (+7.58 %) |
Feb 28 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | A | 100.38 | 25,376 | 2,547,243 | 25,376 | |
Feb 28 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 7,544 | 0 | 90,720 | 83.2 K to 90.7 K (+9.07 %) |
Feb 28 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 100.38 | 2,733 | 274,339 | 83,176 | 85.9 K to 83.2 K (-3.18 %) |
Feb 28 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 5,239 | 0 | 85,909 | 80.7 K to 85.9 K (+6.49 %) |
Feb 28 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 104.28 | 725 | 75,603 | 80,670 | 81.4 K to 80.7 K (-0.89 %) |
Feb 28 2017 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 104.28 | 1,642 | 171,228 | 81,395 | 83 K to 81.4 K (-1.98 %) |
Jan 05 2017 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | A | 1.19 | 16,000 | 19,040 | 16,000 | |
Nov 30 2016 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Option Exercise | A | 2.37 | 7,000 | 16,590 | 7,000 | |
Nov 15 2016 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | P | 1.21 | 13,000 | 15,678 | 39,250 | 26.3 K to 39.3 K (+49.52 %) |
Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 4,125 | 41,126 | 66,735 | |
Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 12,500 | 124,625 | 70,860 | |
Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 4,125 | 41,126 | 83,037 | 78.9 K to 83 K (+5.23 %) |
Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 122.14 | 12,500 | 1,526,750 | 78,912 | 91.4 K to 78.9 K (-13.67 %) |
Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 12,500 | 124,625 | 91,412 | 78.9 K to 91.4 K (+15.84 %) |
Mar 17 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 2,250 | 22,433 | 83,360 | |
Mar 17 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 6,400 | 63,808 | 85,610 | |
Mar 17 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 2,250 | 22,433 | 78,912 | 76.7 K to 78.9 K (+2.93 %) |
Mar 17 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 96.70 | 6,400 | 618,880 | 76,662 | 83.1 K to 76.7 K (-7.71 %) |
Mar 17 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 6,400 | 63,808 | 83,062 | 76.7 K to 83.1 K (+8.35 %) |
Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | A | 85.79 | 27,080 | 2,323,193 | 27,080 | |
Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 85.97 | 1,642 | 141,163 | 76,662 | 78.3 K to 76.7 K (-2.10 %) |
Feb 16 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 5,676 | 0 | 78,304 | 72.6 K to 78.3 K (+7.82 %) |
Apr 13 2016 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Option Exercise | P | 1.50 | 20,000 | 30,000 | 20,000 | |
Apr 13 2016 | VKTX | Viking Therapeutic ... | FOEHR MATTHEW W | Director | Buy | P | 1.24 | 20,000 | 24,800 | 26,250 | 6.3 K to 26.3 K (+320.00 %) |
Jan 11 2016 | RTTR | RITTER PHARMACEUTI ... | FOEHR MATTHEW W | Director | Buy | P | 1.64 | 13,000 | 21,320 | 17,000 | 4 K to 17 K (+325.00 %) |